Structure | Chemical Name | CAS | MF |
|
S-3'-deoxy-3-deazaadenosylhomocysteine
|
110880-45-0
|
C15H21N5O4S
|
|
S-3'-deoxy-7-deazaadenosylhomocysteine
|
110880-46-1
|
C15H21N5O4S
|
|
(N-ME-PHE7)-NEUROKININ B
|
110880-53-0
|
C60H81N13O14S2
|
|
substance P, Pro(9)-Met(O2)(11)-
|
110880-54-1
|
C66H102N18O15S
|
|
(SAR9,MET(O2)11)-SUBSTANCE P
|
110880-55-2
|
C64H100N18O15S
|
|
enkephalin-Leu, Ala(2)-Cys(6)-
|
110881-59-9
|
C32H44N6O8S
|
|
N-(3,4-diacetoxycinnamoyl)-2-pyrrolidone
|
110882-08-1
|
C17H17NO6
|
|
N-caffeoyl-4-aminobutyric acid
|
110882-10-5
|
C13H15NO5
|
|
3-FLUORO-5-NITROBENZONITRILE
|
110882-60-5
|
C7H3FN2O2
|
|
Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, hydrazide, exo- (9CI)
|
110882-66-1
|
C8H12N2O
|
|
N-(2-CHLORO-3-NITRO-6-PYRIDYL)ACETAMIDE
|
110882-70-7
|
C7H6ClN3O3
|
|
Propanamide, N-(5-ethoxy-2-hydroxyphenyl)- (9CI)
|
110882-73-0
|
C11H15NO3
|
|
2-[(4-Ethylphenyl)-phenylacetyl]-indan-1,3-dione
|
110882-80-9
|
C25H20O3
|
|
parvodicin A
|
110882-81-0
|
C81H84Cl2N8O29
|
|
1-[2-(Dimethylamino)ethyl]-4,6,7-trimethoxydibenz[b,f]oxepin
|
110883-34-6
|
C21H25NO4
|
|
(1S,8aα)-Decahydro-5α-(1H-indol-3-ylmethyl)-1β,4aβ-dimethyl-6-methylene-1-(4-methyl-3-pentenyl)naphthalen-2β-ol
|
110883-36-8
|
C28H39NO
|
|
(1S,8aα)-Decahydro-5β-(1H-indol-3-ylmethyl)-1β,4aβ-dimethyl-6-methylene-1-(4-methyl-3-pentenyl)naphthalen-2β-ol
|
110883-37-9
|
C28H39NO
|
|
Giracodazole
|
110883-46-0
|
C6H11ClN4O
|
|
5-Methoxy-1H-pyrazol-3-aMine hydrochloride
|
110884-53-2
|
C4H8ClN3O
|
|
CHOLESTEROL-3-OCTANOATE (Octanoate-1-13C, 99%)
|
110888-06-7
|
C43H76O4
|
|
Propanenitrile, 2-amino-3-phenoxy-
|
110888-09-0
|
C9H10N2O
|
|
4-Chloro-3-fluorobenzonitrile
|
110888-15-8
|
C7H3ClFN
|
|
3-Fluoro-4-Mercaptobenzonitrile
|
110888-16-9
|
C7H4FNS
|
|
Cyclopropanecarboxamide, 2-ethenyl-N,N,1-trimethyl- (9CI)
|
110890-16-9
|
C9H15NO
|
|
Cyclopropanecarboxamide, 2-ethenyl-N,N,2-trimethyl- (9CI)
|
110890-19-2
|
C9H15NO
|
|
(Z)-1,1-Dichloro-2-butene
|
110890-41-0
|
C4H6Cl2
|
|
2-Cyclohexen-1-ol, 1-(3-buten-1-ynyl)- (9CI)
|
110890-53-4
|
C10H12O
|
|
2-Cyclopenten-1-ol, 1-(3-buten-1-ynyl)-2-methyl- (9CI)
|
110890-55-6
|
C10H12O
|
|
Ethanol, 2-(1H-benzimidazol-5-ylamino)- (9CI)
|
110893-12-4
|
C9H11N3O
|
|
Isopropyl 3-cyanobenzoate
|
110893-37-3
|
C11H11NO2
|
|
1-PIPERAZIN-1-YL-3-M-TOLYLOXY-PROPAN-2-OL
|
110894-01-4
|
C14H22N2O2
|
|
3-(4,4'-DIMETHOXYTRITYL)PROPANDIOL-1-N,N-DIISOPROPYL (BETA-CYANOETHYL) PHOSPHORAMIDITE
|
110894-23-0
|
C33H43N2O5P
|
|
1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole
|
110895-43-7
|
|
|
TRIAZAMATE
|
110895-51-7
|
C11H18N4O3S
|
|
2,4,5-trihydroxy-1-tetralone
|
110901-27-4
|
C10H10O4
|
|
2,4,8-trihydroxy-1-tetralone
|
110901-28-5
|
|
|
Cyclohexanecarboxamide, 2-amino-, (1R,2R)-rel- (9CI)
|
110901-40-1
|
C7H14N2O
|
|
2-[(1S,2R)-2-(dipropylamino)cyclopropyl]phenol
|
110901-82-1
|
C15H23NO
|
|
Phenol, 3-(2-(dipropylamino)cyclopropyl)-, (1S-trans)-
|
110901-84-3
|
C15H23NO
|
|
9,10-Bis(4-methoxyphenyl)-2-chloroanthracene
|
110904-87-5
|
C28H21ClO2
|
|
Phosphonic acid, (4-oxo-2-butenyl)-, diethyl ester, (E)-
|
110905-37-8
|
C8H15O4P
|
|
Benzoyl fluoride, 2-(1,1-dimethylethyl)- (9CI)
|
110906-27-9
|
C11H13FO
|
|
SUC-PHE-ALA-ALA-PHE-PNA
|
110906-89-3
|
C34H38N6O9
|
|
2,3-BIS(ACETYLOXY)-(2ALPHA,3ALPHA)-URS-12-EN-28-OIC ACID
|
110906-94-0
|
C34H52O6
|
|
RpIII toxin (Radianthus)
|
110908-25-3
|
|
|
Cathepsin E
|
110910-42-4
|
|
|
OppB protein, Salmonella
|
110910-52-6
|
|
|
OppC protein
|
110910-53-7
|
|
|
1H-Pyrrole-1-carboxylicacid,2,3-dihydro-,2-propenylester(9CI)
|
110910-76-4
|
C8H11NO2
|
|
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 2-ethoxy-7-methyl- (9CI)
|
110911-77-8
|
C11H11N3O
|
|
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 2-ethoxy-5-methyl- (9CI)
|
110911-78-9
|
C11H11N3O
|
|
3-CHLORO-1H-INDOLE-2-CARBALDEHYDE
|
110912-15-7
|
C9H6ClNO
|
|
bis(2,6-anhydro-1-thio-glycero-manno-heptitol)mercuy(II)
|
110913-60-5
|
C30H42HgO18S2
|
|
2,6-anhydro-S-(ethylmercury(II))-1-thio-glycero-manno-heptitol
|
110913-61-6
|
C17H26HgO9S
|
|
6-amino-1-(2-deoxypentofuranosyl)-1H-pyrrolo(3,2-c)pyridin-4(5H)-one
|
110914-68-6
|
C12H15N3O4
|
|
6-amino-1-arabinofuranosyl-1H-pyrrolo(3,2-c)pyridin-4(5H)-one
|
110914-71-1
|
C12H15N3O5
|
|
Cyclopropanecarboxamide, 2-ethenyl-N,N,3-trimethyl- (9CI)
|
110915-17-8
|
C9H15NO
|
|
Benzenepropanoic acid, alpha-fluoro-beta-hydroxy-3-methoxy-, (R*,S*)- (9CI)
|
110915-68-9
|
C10H11FO4
|
|
Benzoic acid, ethyl ester, conjugate monoacid (9CI)
|
110915-76-9
|
C9H11O2+
|
|
(R)-2-AMINO-2-METHYL-PENTANOIC ACID
|
110916-84-2
|
C6H13NO2
|
|
4-[(Z)-2-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalene-2-yl)-1-propenyl]benzoic acid
|
110917-84-5
|
C24H28O2
|
|
2-Pyridinamine,5-fluoro-6-methyl-(9CI)
|
110919-71-6
|
C6H7FN2
|
|
Benzoyl chloride, 4-mercapto- (9CI)
|
110922-46-8
|
C7H5ClOS
|
|
3-METHOXY-AZETIDINE
|
110925-17-2
|
C4H9NO
|
|
1H-Benzimidazole-5-acetonitrile(9CI)
|
110925-52-5
|
C9H7N3
|
|
1H-Benzimidazole-5-ethanamine(9CI)
|
110925-53-6
|
C9H11N3
|
|
1-Phenyl-1-chloro-2-methylaminopropane hydrochloride, Chloroephedrine HCL
|
110925-64-9
|
C10H14ClN
|
|
3-deoxy-3-fluorofructose
|
110925-86-5
|
C6H11FO5
|
|
ROXATIDINE OXALATE
|
110925-92-3
|
C19H28N2O7
|
|
OXAZOL-4-AMINE
|
110926-01-7
|
C3H4N2O
|
|
3,4-Dihydro-6,7-dimethoxy-4-methyl-3-oxo-2-quinoxalinecarboxylic acid azide
|
110926-94-8
|
|
|
5-methoxy-3-(di-n-propylamino)chroman
|
110927-00-9
|
C16H25NO2
|
|
3,4-Dihydro-5-methoxy-2H-1-Benzopyran-3-amine
|
110927-03-2
|
C10H13NO2
|
|
22-hydroxycholecalciferol
|
110927-46-3
|
C27H44O2
|
|
didehydrofalcarinol
|
110927-49-6
|
C17H20O
|
|
1,4-Bis(4-carbamoylanilino)-9,10-anthraquinone
|
110927-96-3
|
C28H20N4O4
|
|
(1r,4r)-methyl 4-(hydroxymethyl)cyclohexanecarboxylate
|
110928-44-4
|
C9H16O3
|
|
3-Cyclopentene-1,2-dione, 5,5-dichloro-
|
110930-98-8
|
C5H2Cl2O2
|
|
2,5-Cyclohexadiene-1,4-dione, 2-chloro-3-hydroxy-
|
110931-02-7
|
C6H3ClO3
|
|
N-(1,1'-biphenyl-4-ylmethyl)-N-methylamine
|
110931-72-1
|
C14H15N
|
|
1-(benzo[d][1,3]dioxol-4-yl)-N-methylmethanamine
|
110931-73-2
|
C9H11NO2
|
|
N-(1-naphthylmethyl)cyclopropanamine
|
110931-74-3
|
C14H15N
|
|
(2,3-dimethylbenzyl)methylamine(SALTDATA: FREE)
|
110931-75-4
|
C10H15N
|
|
3-(2',4'-DIFLUOROBENZOYL)PROPIONIC ACID
|
110931-77-6
|
C10H8F2O3
|
|
2,4-DIFLUOROPHENYLBUTYRIC ACID
|
110931-78-7
|
C10H10F2O2
|
|
5,7-DIFLUORO-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE
|
110931-79-8
|
C10H8F2O
|
|
5-Fluoro-1-naphthaldehyde
|
110931-86-7
|
C11H7FO
|
|
ART-CHEM-BB B018354
|
110932-40-6
|
C16H11NOS2
|
|
Flutriafol IMpurity D
|
110933-21-6
|
C16H13F2N3O
|
|
3-(N-(4-pyridino)carbamoyl)methyl-3,4,4-trimethyl-1,2-dioxetane
|
110933-25-0
|
C12H16N2O3
|
|
azoxybenzene-3,3',5,5'-tetracarboxylic acid
|
110935-44-9
|
C16H10N2O9
|
|
Fokalhydran
|
110941-94-1
|
|
|
HUMAN IL-2
|
110942-02-4
|
|
|
Ethanone, 2-chloro-1-[4-(dimethylamino)phenyl]- (9CI)
|
110945-00-1
|
C10H12ClNO
|
|
Paxisterol
|
110945-69-2
|
C28H42O4
|
|
dichloro-(3-(methyleneiminodiacetic acid)phenyl-(2',3'-diaminopropionamide))platinum(II)
|
110947-34-7
|
C14H20Cl2N4O5Pt
|
|
dichloro-(4-methyleneiminodiacetic acid)phenyl-(2',3'-diaminopropionamide)platinum(II)
|
110947-38-1
|
C16H24Cl2N4O5Pt
|
|
1-Phenol-4-sulfonic acid acetate potassium salt
|
110949-38-7
|
C8H7KO5S
|
|
Quinoline, 6-ethoxy-1,2-dihydro-1,2,2-trimethyl- (9CI)
|
110951-55-8
|
C14H19NO
|
|
6-[(1,2,3,4-Tetrahydro-1,1,4,4-tetramethylnaphthalene)-6-ylcarbonyl]-2-naphthalenecarboxylic acid
|
110952-26-6
|
C26H26O3
|